Rarebase is a public benefit biotech company that aims to revolutionize drug discovery with a focus on speed and scale. Founded in 2020 and based in the San Francisco Bay Area, the company is led by a team of patients, scientists, advocates, and engineers. Rarebase employs high-throughput technology and proven scientific methods to develop disease-modifying therapies for a multitude of diseases simultaneously. The company is known for its commitment to innovation in the field of biotechnology and its dedication to addressing the needs of medically underserved patient communities.